BioDuro Email Format
Pharmaceutical ManufacturingCalifornia, United States201-500 Employees
BioDuro is a contract research, development, and manufacturing organization (CRDMO) in the pharmaceutical manufacturing industry with 30 years of operation. The company is headquartered in Irvine, California (9601 Jeronimo Road, Irvine, 92618), and it also operates in China, with 7 global sites across 6 cities and a workforce that includes more than 2,000 scientists and 201-500 employees. BioDuro provides fully integrated services from target identification through commercial drug product manufacturing, with core capabilities in small and large molecule discovery, development and scale-up, IND submission support, and bioavailability enhancement of insoluble compounds. It follows a one-stop operation model and adheres to a global standard of compliance to support biotech and pharmaceutical partners in accelerating discovery and de-risking development. Recent developments include expansion to Taiwan via a Cenra API Solutions joint venture, integration with Cenra to combine early-stage development with commercial-scale GMP API manufacturing, and the 2026 acquisition of BioDuro's Irvine operations by BioSelective Capital Investments, along with leadership changes such as Yaohui Ji being named Global President, CMC, effective January 1, 2026.